Hypoxia: Clinical Trials

3 trials for Hypoxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 3
Phase 21Active not recruiting 1

Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Optimization of Caffeine for HIE
Caffeine citrate 20 mg/kg, Caffeine citrate 30 mg/kg - Hypoxic-Ischemic Encephalopathy
Phase 1Active not recruitingUniversity of North Carolina, Chapel Hill162024-07-262026-08-14
Adenosine 2A Receptor Antagonism and AIH in ALS
Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug - ALS
Phase 1 / Phase 2Active not recruitingUniversity of Florida402022-06-212026-03-27
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
Methylphenidate - Brain Injury Traumatic Severe (Diagnosis), Coma
Phase 1Active not recruitingMassachusetts General Hospital102020-08-242025-10-29

Narrower conditions

Hypoxia-Ischemia, Brain (2)  ·  Coma (1)  ·  Consciousness Disorders (1)  ·  Disease (1)  ·  Respiratory Aspiration (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Signs and Symptoms, Respiratory (3)  ·  Brain Diseases (2)  ·  Brain Ischemia (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Hypoxia, Brain (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Vascular Diseases (2)  ·  Mental Disorders (1)  ·  Neurobehavioral Manifestations (1)

Interventions

5,10-dihydro-5-methylphenazine (1)  ·  Insemination, Artificial, Homologous (1)  ·  Methylphenidate (1)  ·  caffeine citrate (1)  ·  istradefylline (1)

Sponsors

Massachusetts General Hospital (1)  ·  University of Florida (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (3)

Top investigators

Barbara Smith (1)  ·  Brian L Edlow, MD (1)  ·  Wesley M Jackson, MD, MPH (1)

Results publications

PMID 41202295

NIH funding

DP2HD101400 (1), K23HD111623 (1)